the therapeutic effect of low-dose mtx-treatment ( 10-25 mg/week ) in active rheumatoid arthritis can be demonstrated by an improvement in clinical and laboratory parameters of disease activity already after 4-6 weeks .
C0025677
mtx
C0003873
rheumatoid arthritis